PKC-epsilon, 220.127.116.11, VAV-1, Ca('2+) endoplasmic reticulum lumen, Rac1, c-Jun, c-Src, p130CAS, PLC-gamma 1, Angiotensin II receptor, type-1, Ca('2) cytosol, PI3K reg class IA, c-Fos, Elk-1, IP3 receptor, ATF-2/c-Jun, <endoplasmic reticulum lumen> Ca('2+) = <cytosol> Ca('2+), PAK1, c-Raf-1, Pyk2(FAK2), IP3, ERK1 (MAPK3), GRB2, MEK4(MAP2K4), MEK1(MAP2K1), MEK2(MAP2K2), MEKK1(MAP3K1), PKC-delta, c-Jun/c-Fos, PLC-beta, H-Ras, SOS, DAG, Calmodulin, ATF-2, Angiotensin II, ERK2 (MAPK1), CaMK II, G-protein beta/gamma, JNK(MAPK8-10), PtdIns(4,5)P2, G-protein alpha-q/11, Shc
Angiotensin activation of MAPKs via Pyk2
Angiotensin II, a major effector peptide of the renin-angiotensin system, is believed to play a critical role in the pathogenesis of cardiovascular remodeling associated with hypertension, heart failure, and atherosclerosis. 
Angiotensin II receptor, type-1 mediates major cardiovascular effects of Angiotensin II. It belongs to the guanine nucleotide-binding regulatory protein (G protein)-coupled receptor (GPCR) superfamily.  Human Angiotensin II receptor, type-1 is found in liver, lung, adrenal, and adrenocortical adenomas .
In general terms, the mechanisms used by GPCRs to stimulate mitogen-activated protein kinases (MAPKs) fall into one of several broad categories. One of the important mechanisms involves the cross-talk between GPCRs and classical receptor tyrosine kinase, e.g., Epidermal growth factor receptor ( EGFR ). This process is called transactivation.
Upon binding with Angiotensin II the Angiotensin II receptor, type-1 is stabilized in its active conformation and stimulates heterotrimeric G proteins (most notably G q/11). These G-proteins dissociate into alpha ( G-protein alpha-q/11 ) and beta/gamma ( G-protein beta/gamma ) subunits . Both subunits take part in the activation of mitogen-activated protein kinase cascade.
G-protein alpha-q/11 and G-protein beta/gamma act as signal transducers for activation of the Phospholipase C beta ( PLC-beta ) . PLC-beta activation leads to hydrolysis of Phosphatidylinositol 4,5-bisphosphate ( PtdIns(4,5)P2 ) and formation of Diacylglycerol ( DAG ) and Inositol trisphosphate ( IP3 ). DAG and IP3 stimulate the Protein kinase C (e.g., PKC-delta and PKC-epsilon) and mobilize intracellular Ca2+, respectively. These effectors are believed to mediate most of the well established acute responses to Angiotensin II, including vasoconstriction, aldosterone biosynthesis and thirst/salt appetite .
Angiotensin II receptor, type-1 induces activation of Ca2+/ Calmodulin -dependent protein kinase II ( CaMK II ), PKC-delta and PKC-epsilon. These kinases phosphorylate PTK2B protein tyrosine kinase 2 beta ( Pyk2(FAK2) ) and activate it , .
Pyk2(FAK2) is a key tyrosine kinase in the early events of the Angiotensin II signaling. It is a point of split of the Angiotensin II signaling.
Pyk2(FAK2) -dependent phosphorylation and interaction with the adapter molecule protein Crk-associated substrate ( p130CAS ) lead to their association with the p85 regulatory subunit of Phosphatidylinositol 3-kinase ( PI3K reg class 1A (p85) ) , .
This complex formation leads to the activation of PI3K and to regulation of important cell processes, e.g., protein synthesis via regulation of the Eukaryotic initiation factor 4E (eIF4E)/eIF4E-bindind protein (4E-BP) complex .
Pyk2(FAK2) is the main mediator responsible for the transmission of Angiotensin II signals to Ras-related C3 botulinum toxin substrate 1 ( Rac1 ) via, e.g, Guanine nucleotide exchange factor VAV-1 ,  ). Activated Rac1 stimulates the cascade that involves p21-Activated kinase 1 ( PAK1 )/ Mitogen-activated protein kinase kinase kinase 1 ( MEKK1 )/ Dual specificity mitogen-activated protein kinase kinase 4 ( MEK4 )/c-Jun N-terminal kinase ( JNK(MAPK8-10) ). Tyrosine-protein kinase v-Src sarcoma viral oncogene homolog ( c-Src ) is also partially involved in Rac1 activation .
c-Src in turn may activates Phospholipase C gamma 1 ( PLC-gamma 1 ) that plays the same role as PLC-beta .
In additional, Pyk2(FAK2) acts as an upstream regulator of two parallel signaling pathways, ERK and PI3K pathways. The formation of the complex between Src homology 2 domain containing transforming protein ( Shc ) and Growth factor receptor bound 2 ( GRB2 ) leads to activation of the Son of sevenless proteins ( SOS )/ v-Ha-ras Harvey rat sarcoma viral oncogene homolog ( H-Ras )/ v-Raf-1 murine leukemia viral oncogene homolog 1 ( c-Raf-1 )/ Mitogen-activated protein kinase kinase 1 and 2 ( MEK1 and MEK2 )/ Mitogen-activated protein kinases 1 and 3 ( ERK2 and ERK1 ) cascade , .
Activation by Angiotensin II leads to nuclear translocation of the ERK1, ERK2 and JNK(MAPK8-10) kinases, as well as to activation of transcription factors, e.g. c-Fos, c-Jun, ATF-2, and Elk-1. Many of these factors can form different AP-1 complexes, e.g. ATF-2/c-Jun  or c-Jun/c-Fos . Thus, ERK and JNK signaling cascades participate via activation of AP-1 in diverse of cellular functions .